Spondylodiscitis: clinical and magnetic resonance diagnosis
F Maiuri, B Gallicchio, A Manto, F Briganti - Spine, 1997 - journals.lww.com
Study Design. This study reviews 65 patients with spondylodiscitis, both spontaneous and
postoperative and of different etiology, studied by magnetic resonance imaging. Objectives …
postoperative and of different etiology, studied by magnetic resonance imaging. Objectives …
Endovascular treatment of cerebral aneurysms using flow-diverter devices: a systematic review
F Briganti, G Leone, M Marseglia… - The …, 2015 - journals.sagepub.com
Background Flow-diverter devices (FDDs) are new-generation stents placed in the parent
artery at the level of the aneurysm neck to disrupt the intra-aneurysmal flow thus favoring …
artery at the level of the aneurysm neck to disrupt the intra-aneurysmal flow thus favoring …
Orbital fractures: role of imaging
F Caranci, D Cicala, S Cappabianca, F Briganti… - Seminars in Ultrasound …, 2012 - Elsevier
The orbit may be injured directly or indirectly. Blunt and penetrating trauma occurs with
equal frequency. Soft tissue swelling often obscures direct clinical evaluation of the globe …
equal frequency. Soft tissue swelling often obscures direct clinical evaluation of the globe …
Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia
A Colao, AD Sarno, P Cappabianca… - European Journal of …, 2003 - academic.oup.com
Background Gender differences in tumor size are supposed to exist in hyperprolactinemia
since microadenomas are more commonly found in women and macroadenomas in men …
since microadenomas are more commonly found in women and macroadenomas in men …
Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen …
The outcome of 24 months of cabergoline treatment on prolactin (PRL) normalization, tumor
shrinkage, restoration of pituitary function, and semen alterations was prospectively …
shrinkage, restoration of pituitary function, and semen alterations was prospectively …
Epidemiology and genetics of intracranial aneurysms
F Caranci, F Briganti, L Cirillo, M Leonardi… - European journal of …, 2013 - Elsevier
Intracranial aneurysms are acquired lesions (5–10% of the population), a fraction of which
rupture leading to subarachnoid hemorrhage with devastating consequences. Until now, the …
rupture leading to subarachnoid hemorrhage with devastating consequences. Until now, the …
Italian multicenter experience with flow-diverter devices for intracranial unruptured aneurysm treatment with periprocedural complications—a retrospective data …
Introduction We report the experiences of 25 Italian centers, analyzing intra-and
periprocedural complications of endovascular treatment of intracranial aneurysms using Silk …
periprocedural complications of endovascular treatment of intracranial aneurysms using Silk …
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog …
A Colao, R Pivonello, RS Auriemma… - European Journal of …, 2006 - academic.oup.com
Objective We aimed to investigate the efficacy of pegvisomant in patients with acromegaly
resistant to long-term (≧ 24-month), high-dose treatment with octreotide-LAR (40 mg/month) …
resistant to long-term (≧ 24-month), high-dose treatment with octreotide-LAR (40 mg/month) …
Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients
G Servillo, P Striano, S Striano, F Tortora… - Intensive care …, 2003 - Springer
Objective To describe clinical, neuroradiological and evolutionary findings in obstetric
patients with posterior reversible encephalopathy syndrome (PRES). Design Retrospective …
patients with posterior reversible encephalopathy syndrome (PRES). Design Retrospective …
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients
A Colao, R Pivonello, RS Auriemma… - The Journal of …, 2006 - academic.oup.com
Context: Primary treatment with depot octreotide and lanreotide induces tumor shrinkage in
newly diagnosed patients with acromegaly. Objective: The objective of the study was to …
newly diagnosed patients with acromegaly. Objective: The objective of the study was to …